Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Irwin Naturals Inc. (C:IWIN)

Business Focus: Pharmaceuticals Wholesale

Get the company report for the most recent outlook updated daily

Insider Chart - Past 6 Months

Insider Filings

Latest 10 SEDI filings for IWIN within the last 6 months
Loading...
See all filings within the past 6 months

Company News

Nov 27, 2023 19:06 ET
Irwin Naturals Reports Q3 2023 Financial Results
Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) reported its financial results for its third quarter of fiscal 2023, the period ended September 30, 2023, on www.sedar.com. Financial Highlights for Q3 2023 Q3...
Read full article
Aug 28, 2023 07:30 ET
Irwin Naturals Reports Q2 2023 Financial Results
Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) reported its financial results for its second quarter of fiscal 2023, the period ended June 30, 2023, on www.sedar.com. Financial Highlights for Q2 2023 Q2...
Read full article
See more news stories

Valuation Ratios

Industry
Sector
Beta
N/A
--
--
Price to Sales - TTM
0.01
0.68
3.46
Price to Book - most recent quarter
6.84
2.64
2.02
Price to Cash Flow per share - TTM
--
10.92
9.70
Price to Free Cash Flow per share - TTM
--
6.45
12.33
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Mar 15, 20243870
Feb 15, 202410141
Jan 31, 202460-244
See Short Report

Business Summary

Sector:  Healthcare Industry:  Pharmaceuticals

Irwin Naturals Inc. (Irwin) is a nutraceutical company. The Company is engaged in distributing cannabidiol (CBD) products in mass-market and health food chain stores across the United States. Irwin's portfolio of herbal products is available in more than 100,000 retail doors across North America. The Company's full range of Vitamin, CBD, and Supplements features over 100 products, created to address mood and brain function, better sleep, sports performance, sexual health, immune support, weight management, women's health and men's health. The Company's ketamine clinic, Emergence, is an infusion clinic that offers intravenous (IV) ketamine for the treatment of depression, post-traumatic stress disorder (PTSD), obsessive-compulsive disorder (OCD), anxiety, bipolar disorder, migraines, and multiple chronic pain conditions such as complex regional pain syndrome (CRPS), reflex sympathetic dystrophy (RSD) and fibromyalgia.

See business summary

 

Twitter

Search (past week) for $IWIN.CA

  • No tweets found